UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 237.10
+0.70 (0.30%)
At close: Dec 30, 2025
UCB SA Market Cap
UCB SA has a market cap or net worth of €45.05 billion as of December 30, 2025. Its market cap has increased by 26.67% in one year.
Market Cap
45.05B
Enterprise Value
46.32B
Revenue
6.85B
Ranking
n/a
PE Ratio
34.53
Stock Price
€237.10
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 45.05B, an increase of 4,957.80%. That is a compound annual growth rate of 13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 45.05B | 23.54% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 43.98B |
| Financière de Tubize | 9.30B |
| Fagron NV | 1.56B |
| Ion Beam Applications | 355.30M |
| Onward Medical | 187.90M |
| Nyxoah | 175.12M |
| Hyloris Pharmaceuticals | 165.20M |
| Sequana Medical NV | 39.44M |